Loading...
Keywords
Last Name
Institution

Connection

Rangaraj Selvarangan to Parechovirus

This is a "connection" page, showing publications Rangaraj Selvarangan has written about Parechovirus.

 
Connection Strength
 
 
 
7.770
 
  1. Sasidharan A, Harrison CJ, Selvarangan R. Diagnosis, management, and outcomes of parechovirus infections in infants: an overview. J Clin Microbiol. 2024 Jun 12; 62(6):e0113923.
    View in: PubMed
    Score: 0.911
  2. Lee BR, Sasidharan A, Harrison CJ, Selvarangan R. Disruption of seasonal enterovirus and parechovirus detections in the CSF and plasma of children during the COVID-19 pandemic. J Clin Virol. 2023 03; 160:105381.
    View in: PubMed
    Score: 0.836
  3. Klatte JM, Harrison CJ, Pate B, Queen MA, Neuhart J, Jackson MA, Selvarangan R. Maternal parechovirus A (PeV-A) shedding, serostatus, and the risk of central nervous system PeV-A infections in infants. J Clin Virol. 2021 09; 142:104939.
    View in: PubMed
    Score: 0.754
  4. Sasidharan A, Banerjee D, Harrison CJ, Selvarangan R. Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016. J Clin Microbiol. 2021 05 19; 59(6).
    View in: PubMed
    Score: 0.744
  5. Kilbride H, Jackson MA, Selvarangan R. Childhood Outcomes Following Parechovirus Infections in a US Young Infant Cohort. Pediatr Infect Dis J. 2021 04 01; 40(4):295-299.
    View in: PubMed
    Score: 0.737
  6. Lee BR, Sasidharan A, Harrison CJ, Selvarangan R. Positive Impact of Routine Testing for Enterovirus and Parechovirus on Length of Hospitalization and Antimicrobial Use among Inpatients =6 Months of Age. J Clin Microbiol. 2020 12 17; 59(1).
    View in: PubMed
    Score: 0.722
  7. Rhoden E, Nix WA, Weldon WC, Selvarangan R. Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae). Antiviral Res. 2018 01; 149:75-77.
    View in: PubMed
    Score: 0.583
  8. Sharp J, Harrison CJ, Puckett K, Selvaraju SB, Penaranda S, Nix WA, Oberste MS, Selvarangan R. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J. 2013 Mar; 32(3):213-6.
    View in: PubMed
    Score: 0.421
  9. Selvaraju SB, Nix WA, Oberste MS, Selvarangan R. Optimization of a combined human parechovirus-enterovirus real-time reverse transcription-PCR assay and evaluation of a new parechovirus 3-specific assay for cerebrospinal fluid specimen testing. J Clin Microbiol. 2013 Feb; 51(2):452-8.
    View in: PubMed
    Score: 0.413
  10. Sharp J, Bell J, Harrison CJ, Nix WA, Oberste MS, Selvarangan R. Human parechovirus in respiratory specimens from children in Kansas City, Missouri. J Clin Microbiol. 2012 Dec; 50(12):4111-3.
    View in: PubMed
    Score: 0.408
  11. Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J. 2011 Mar; 30(3):238-42.
    View in: PubMed
    Score: 0.366
  12. Romero JR, Selvarangan R. The human Parechoviruses: an overview. Adv Pediatr. 2011; 58(1):65-85.
    View in: PubMed
    Score: 0.362
  13. Sasidharan A, Harrison CJ, Banerjee D, Selvarangan R. Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA. J Clin Microbiol. 2019 05; 57(5).
    View in: PubMed
    Score: 0.161
  14. Karelehto E, Brouwer L, Benschop K, Kok J, Basile K, McMullan B, Rawlinson W, Druce J, Nicholson S, Selvarangan R, Harrison C, Lankachandra K, van Eijk H, Koen G, de Jong M, Pajkrt D, Wolthers KC. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis. 2019 01; 25(1):148-152.
    View in: PubMed
    Score: 0.158
  15. Midgley CM, Jackson MA, Selvarangan R, Franklin P, Holzschuh EL, Lloyd J, Scaletta J, Straily A, Tubach S, Willingham A, Nix WA, Oberste MS, Harrison CJ, Hunt C, Turabelidze G, Gerber SI, Watson JT. Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):104-112.
    View in: PubMed
    Score: 0.151
  16. Rhoden E, Ng TFF, Campagnoli R, Nix WA, Konopka-Anstadt J, Selvarangan R, Briesach L, Oberste MS, Weldon WC. Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle. Antimicrob Agents Chemother. 2020 02 21; 64(3).
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.